These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8850108)

  • 61. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):720-6. PubMed ID: 9732339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical effect of captopril in diabetic patients with complicated acute myocardial infarction].
    Liu Z; Wang J; Yang S
    Zhonghua Nei Ke Za Zhi; 1999 Jun; 38(6):380-2. PubMed ID: 11798671
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost-benefit analysis--a prerequisite of a rational pharmacotherapy in cardiovascular diseases. Timely thrombolysis in the acute myocardial infarction.
    Barthel W; Haustein KO
    Int J Clin Pharmacol Ther; 1996 Jul; 34(7):277-81. PubMed ID: 8832302
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J
    Am J Cardiol; 1999 Feb; 83(4):477-81. PubMed ID: 10073846
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Care of patients with a low probability of acute myocardial infarction. Cost effectiveness of alternatives to coronary-care-unit admission.
    Fineberg HV; Scadden D; Goldman L
    N Engl J Med; 1984 May; 310(20):1301-7. PubMed ID: 6425687
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Treatment with ACE inhibitors after acute myocardial infarction].
    Haghfelt T; Thayssen P
    Ugeskr Laeger; 1993 Feb; 155(7):492-3. PubMed ID: 8465457
    [No Abstract]   [Full Text] [Related]  

  • 67. Cost-effectiveness of the treatment of heart failure with ramipril: a Spanish analysis of the AIRE study.
    Hart WM; Rubio-Terres C; Pajuelo F; González Juanatey JR
    Eur J Heart Fail; 2002 Aug; 4(4):553-8. PubMed ID: 12167396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An economic analysis of the Survival and Ventricular Enlargement (SAVE) Study. Application to the United Kingdom.
    Hummel S; Piercy J; Wright R; Davie A; Bagust A; McMurray J
    Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):182-92. PubMed ID: 10169670
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group.
    Rodby RA; Firth LM; Lewis EJ
    Diabetes Care; 1996 Oct; 19(10):1051-61. PubMed ID: 8886549
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost effectiveness of ramipril in patients at high risk for cardiovascular events : economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for Germany from the Statutory Health Insurance perspective.
    Schädlich PK; Brecht JG; Rangoonwala B; Huppertz E
    Pharmacoeconomics; 2004; 22(15):955-73. PubMed ID: 15449961
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction: results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE).
    Kleber FX; Sabin GV; Winter UJ; Reindl I; Beil S; Wenzel M; Fischer M; Doering W
    Am J Cardiol; 1997 Aug; 80(3A):162A-167A. PubMed ID: 9293972
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.
    Borghi C; Omboni S; Reggiardo G; Bacchelli S; Esposti DD; Ambrosioni E;
    BMC Cardiovasc Disord; 2018 Jun; 18(1):112. PubMed ID: 29866077
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.
    Dong FB; Sorensen SW; Manninen DL; Thompson TJ; Narayan V; Orians CE; Gregg EW; Eastman RC; Dasbach EJ; Herman WH; Newman JM; Narva AS; Ballard DJ; Engelgau MM
    Pharmacoeconomics; 2004; 22(15):1015-27. PubMed ID: 15449965
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study.
    Moyé LA; Pfeffer MA; Wun CC; Davis BR; Geltman E; Hayes D; Farnham DJ; Randall OS; Dinh H; Arnold JM
    Eur Heart J; 1994 May; 15 Suppl B():2-8; discussion 26-30. PubMed ID: 8076658
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Zofenopril after anterior myocardial infarction.
    Chaudhry GM; Haneef N
    N Engl J Med; 1995 Jun; 332(25):1716. PubMed ID: 7760878
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.
    Rutherford JD; Pfeffer MA; Moyé LA; Davis BR; Flaker GC; Kowey PR; Lamas GA; Miller HS; Packer M; Rouleau JL
    Circulation; 1994 Oct; 90(4):1731-8. PubMed ID: 7923656
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J;
    Am J Cardiol; 2001 Mar; 87(6):766-71, A7. PubMed ID: 11249900
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of captopril on ventricular arrhythmias in the early and late phase of suspected acute myocardial infarction. Randomized, placebo-controlled substudy of ISIS-4.
    Budaj A; Cybulski J; Cedro K; Karczmarewicz S; Maciejewicz J; Wiśniewski M; Ceremuzyński L
    Eur Heart J; 1996 Oct; 17(10):1506-10. PubMed ID: 8909907
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The SAVE trial: rational basis, results, and reflections].
    Gomes MC; Maciel MJ
    Rev Port Cardiol; 1992 Sep; 11(9):709-21. PubMed ID: 1476763
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies.
    Borghi C; Omboni S; Reggiardo G; Bacchelli S; Degli Esposti D; Ambrosioni E
    J Cardiovasc Pharmacol; 2017 Jan; 69(1):48-54. PubMed ID: 27798417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.